Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

NCT01147601 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Hemangioma
Infant

Interventions

DRUG: topical 0.5% Timolol
DRUG: Control (placebo) group

Sponsor

Oregon Health and Science University